Pro-Dex - PDEX Stock Forecast, Price & News

0 brokerages have issued 12 month price targets for Pro-Dex's stock. Their PDEX share price forecasts range from $30.00 to $30.00. On average, they expect the company's stock price to reach $30.00 in the next twelve months. This suggests a possible upside of 98.4% from the stock's current price.
View analysts price targets for PDEX or view top-rated stocks among Wall Street analysts.

Pro-Dex's stock was trading at $23.21 on January 1st, 2022. Since then, PDEX shares have decreased by 34.9% and is now trading at $15.12.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 21st 2022.
View our PDEX earnings forecast.

Pro-Dex, Inc. (NASDAQ:PDEX) issued its earnings results on Thursday, August, 25th. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.18 by $0.20. Pro-Dex had a net margin of 9.17% and a trailing twelve-month return on equity of 17.27%.

3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

Pro-Dex's stock is owned by many different retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (0.29%) and Steward Partners Investment Advisory LLC (0.06%). Insiders that own company stock include Alisha Charlton, Katrina Marie Kramer Philp, Kirk Richard Lee Van Jr, Nicholas John Swenson, Raymond E Cabillot and William James Farrell III.
View institutional ownership trends.

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PDEX stock can currently be purchased for approximately $15.12.

Pro-Dex (NASDAQ:PDEX) has a market capitalization of $54.72 million and generates $42.04 million in revenue each year. The medical instruments supplier earns $3.86 million in net income (profit) each year or $1.03 on an earnings per share basis.

The company employs 117 workers across the globe.

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The official website for the company is www.pro-dex.com. The medical instruments supplier can be reached via phone at (949) 769-3200, via email at investor.relations@pro-dex.com, or via fax at 949-769-3281.